Poor and Unusually Prolonged Oral Absorption of Amphotericin B in Rats

[1]  Sun Hwa Lee,et al.  Pharmacokinetics and pharmacodynamics of bumetanide after intravenous and oral administration to rats: Absorption from various GI segments , 1994, Journal of Pharmacokinetics and Biopharmaceutics.

[2]  Malcolm Rowland,et al.  Physiologic modeling of cyclosporin kinetics in rat and man , 1991, Journal of Pharmacokinetics and Biopharmaceutics.

[3]  T. Prueksaritanont,et al.  The phenomenon and cause of the dose-dependent oral absorption of chlorothiazide in rats: Extrapolation to human data based on the body surface area concept , 1987, Journal of Pharmacokinetics and Biopharmaceutics.

[4]  W. L. Chiou,et al.  Evaluation of potential causes for the incomplete bioavailability of furosemide: Gastric first-pass metabolism , 1983, Journal of Pharmacokinetics and Biopharmaceutics.

[5]  A. Barve,et al.  Linear Correlation of the Fraction of Oral Dose Absorbed of 64 Drugs Between Humans and Rats , 1998, Pharmaceutical Research.

[6]  G. Robbie,et al.  Elucidation of Human Amphotericin B Pharmacokinetics: Identification of a New Potential Factor Affecting Interspecies Pharmacokinetic Scaling , 1998, Pharmaceutical Research.

[7]  J. McElnay,et al.  Studies on the mechanism of gastrointestinal absorption of melphalan and chlorambucil , 2004, Cancer Chemotherapy and Pharmacology.

[8]  P. Robbie.  Amphotericin B: Oral absorption in rats and elucidation of human pharmacokinetics and interspecies scaling. , 1998 .

[9]  H. Yuasa,et al.  Effect of dosing volume on gastrointestinal absorption in rats: analysis of the gastrointestinal disposition of L-glucose and estimation of in vivo intestinal membrane permeability. , 1995, Journal of pharmaceutical sciences.

[10]  J. Kaneene,et al.  Anatomic features and radiographic observations of gastric emptying and small intestinal motility in the rat. , 1993, Laboratory animal science.

[11]  W. L. Chiou,et al.  Intrahepatic distribution of hydrochlorothiazide and quinidine in rats: implications in pharmacokinetics. , 1993, Journal of pharmaceutical sciences.

[12]  J. Mordenti,et al.  Extrapolation of Toxicological and Pharmacological Data from Animals to Humans , 1991 .

[13]  H. Gallis,et al.  Amphotericin B: 30 years of clinical experience. , 1990, Reviews of infectious diseases.

[14]  T. Komai,et al.  Intestinal absorption of choline in rats. , 1987, Journal of pharmacobio-dynamics.

[15]  W. L. Chiou,et al.  Mean hepatic transit time in the determination of mean absorption time. , 1983, Journal of pharmaceutical sciences.

[16]  M. S. Ching,et al.  Absorption of orally administered amphotericin B lozenges. , 1983, British journal of clinical pharmacology.

[17]  C. Prober,et al.  Measurement of amphotericin B in serum or plasma by high-performance liquid chromatography. , 1983, Journal of chromatography.